Advisory Board

André Bourgouin

André Bourgouin was previously the Vice-President of Corporate Intellectual Property of Ipsen Pharma which he joined in 1996. He began his career in the Patent Department of Roussel Uclaf and then joined Pasteur Merieux Connaught (now Sanofi Pasteur) where he held the position of Director, Corporate Intellectual Property. André... Learn More

Dr Steven Bradshaw

Steve Bradshaw leads the life sciences consultancy firm, Valid Insight. He is an experienced leader with expertise gained from a career spanning market access consultancy and healthcare roles.Steve has comprehensive experience and knowledge of market access and pricing dynamics and of healthcare systems and pharmaceutical policy affairs across Euro... Learn More

Stephen Brown

Stephen Brown was previously CTO and co-manager of CMO activities for Vivalis, based in Nantes, Western France. He has worked in the biopharmaceutical industry for 31 years. Prior to Vivalis, Dr Brown was Director, Biological Process Development for Merial and before that, responsible for the Gene Vector Manufacturing site at Transgène, France. Ste... Learn More

David Elder

David P. Elder has over 32 years experience in the pharmaceutical industry working for Sterling, Syntex, SmithKline Beecham and GlaxoSmithKline, where he has worked at various director level positions.  He is currently a director in the Externalization group (SCINOVO). He obtained a BSc degree in Applied Chemistry in 1977 from Northumbria Uni... Learn More

Dean Flanders

As well as being affiliated with the Novartis Institute of Biomedical Research, Dean is also affiliated with the Institute of the University of Basel. 

Ronaldo Galvão

Ronaldo Galvão is the Quality Operations Director -GPSG Brazil at Janssen-Cilag. A role he has held since 2007. Ronaldo's responsibilities include, providing leadership and direction for ANVISA issues for GPSG and J&J site, supporting new product launches in the Brazilian market, and providing leadership for BBC (Behavior Based Compliance) conc... Learn More

Sheraz Gul

Sheraz is Head of Assay Development & Screening at the Fraunhofer Institute for Molecular Biology and Applied Ecology – ScreeningPort. In his role, he is responsible for the management and development of Assay Development and Medium and High Throughput Screening activities for partners across the world. He has 23 years’ experience in both acade... Learn More

Melissa Mudrick

Melissa Mudrick, JD, is Director of Drug Safety and Risk Management at Biogen Idec.  In this capacity she is responsible for oversight of global compliance for Drug Safety, through management of corrective actions, auditing, oversight of training and documentation control, and fostering continuous quality improvement worldwide. Melissa has ov... Learn More

Dr. Aidan Sexton

Dr. Aidan Sexton has a Bachelor of Science in Industrial Chemistry and a Doctorate in Catalysis/Physical Chemistry, both from the University of Limerick. He has more than 25 years of experience; 10 years in research and development and 16+ years in the pharmaceutical industry. He has held a number of senior roles in the areas of Validation, Quali... Learn More

Tomas Skacel

Tomas Skacel was previously Medical Director at Amgen International. His past experience includes, International Medical Director at Amgen International, Zug Switzerland, Clinical Resarch Physician at Eli Lilly Regional Medical Ctr, Vienna, Austria, Product manager, Oncology at Eli Lilly Czech Republic and Physician at University Hospital Olom... Learn More

Jan Vindberg-Larsen

Dr. Andrea Zobel